{"conversation_id": "1280509879153823744", "entities": {"annotations": [{"start": 0, "end": 14, "probability": 0.7621, "type": "Organization", "normalized_text": "Gilead Sciences"}], "urls": [{"start": 210, "end": 233, "url": "https://t.co/7SLLixT02c", "expanded_url": "https://interc.pt/31QxOas", "display_url": "interc.pt/31QxOas", "status": 200, "unwound_url": "https://theintercept.com/2020/07/01/coronavirus-treatment-drug-contracts-trump/?utm_campaign=theintercept&utm_source=twitter&utm_medium=social"}]}, "id": "1280509879153823744", "created_at": "2020-07-07T14:32:00.000Z", "possibly_sensitive": false, "author_id": "2329066872", "reply_settings": "everyone", "text": "Gilead Sciences announced its Covid-19 therapy drug, remdesivir, will cost private insurers $520 for a single vial, hundreds of times its production cost, which researchers have estimated at 93 cents per dose. https://t.co/7SLLixT02c", "public_metrics": {"retweet_count": 251, "reply_count": 14, "like_count": 307, "quote_count": 62}, "lang": "en", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "source": "SocialFlow"}